Inactive Instrument

Highlights Clarus Therapeutics Holdings, Inc.

Equities

CRXT

US18271L1070

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

Health Care Up on Deal Activity -- Health Care Roundup	22-09-06	DJ
Clarus Therapeutics Posts Higher Revenue in Q2; Planned 40% Workforce Cut to be Completed in August	22-08-18	MT
Clarus Therapeutics Posts Higher Revenue in Q2	22-08-18	MT
Clarus Therapeutics Holdings, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-18	CI
Clarus Therapeutics Gets US Patent for Testosterone Replacement Product	22-05-18	MT
Clarus Therapeutics Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-16	CI
Clarus Therapeutics Holdings, Inc Announces Notice of Allowance for Patent Claims Covering JATENZO® (testosterone undecanoate)	22-04-28	CI
Clarus Therapeutics Holdings, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2021	22-03-30	CI
Clarus Announces Initiation of Phase 4 Clinical Trial of JATENZO® (testosterone undecanoate) for the Treatment of Hypogonadal Men with Chronic Kidney Disease	22-03-16	CI
Clarus Therapeutics Holdings, Inc. Announces Strategic Partnerships for JATENZO (testosterone undecanoate) with Vault Health and AssistRx	22-02-24	CI
Clarus Therapeutics Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	21-11-18	CI
Clarus Therapeutics Holdings, Inc. Announces Two Notices of Allowance for Patent Claims Covering JATENZO? (testosterone undecanoate)	21-10-26	CI
Clarus Therapeutics : Working With McGill University to Develop Technology for Rare Diseases Associated With Coenzyme-Q10 Deficiencies	21-09-16	MT
Clarus Therapeutics Holdings, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2021	21-09-15	CI
Clarus Therapeutics, Inc. completed the acquisition of Blue Water Acquisition Corp. from Heights Capital Management, Inc., Lighthouse Investment Partners, LLC and Others in a reverse merger transaction.	21-09-08	CI
Sector Update: Health Care Stock Fading Near Friday Close	21-08-27	MT
Blue Water Acquisition : Shareholders OK Merger With Clarus Therapeutics	21-08-27	MT
Blue Water Acquisition Corp. Reports Earnings Results for the Second Quarter Ended June 30, 2021	21-08-16	CI
Blue Water Acquisition Corp. Reports Earnings Results for the Period from May 22, 2020 to December 31, 2020	21-05-06	CI
Blue Water Acquisition : Clarus Therapeutics to Go Public in SPAC Deal	21-04-27	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Clarus Therapeutics Holdings, Inc.

Equities

CRXT

US18271L1070

Highlights

Filters